REGENCELL BIOSCIENCE HOLDING
RGCNASDAQπ #1495 by market capUS Equity
$6.86βΌ $0.45 (β6.16%)
After hours Β· at closeTrack RGC
Get earnings, price moves & breaking news on Telegram
24hβΌ 6.2%
7dβΌ 30.4%
14dβΌ 26.5%
30dβ² 10.7%
ytdβΌ 67.5%
1yβΌ 59.0%
π¦Market Cap
$3.40B
Small Cap
πRevenue Growth (YoY)
β
πGross Margin
β
π΅FCF Margin
β
βοΈP/S Ratio
β
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $6.82 β $7.19
- 52-Week Range
- $4.51 β $69.00
- Volume (shares)
- 5,152
- Avg Volume (shares)
- β
- Shares Outstanding
- 495.9M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- β
- P/E Ratio
- β
- P/S Ratio
- β
- EPS (TTM)
- $-0.02
- Dividend Yield
- β
- Dilution (1yr)
- +0.0%
REGENCELL BIOSCIENCE HOLDING
RGCFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$12Mβ² +211.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$8Mβ² +135.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
494.7Mβ² +0.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$14Mβ² +$12M YoY
About REGENCELL BIOSCIENCE HOLDING
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
β‘Momentumβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst data unavailable.
Latest News & Updates
News unavailable.